FIELD: pharmacology.
SUBSTANCE: invention relates to a compound of the general formula (I)
, where R1 is -F, and R2 is -H or -F, or R1 is -H, and R2 is -F; which can be used as a medicine for treatment of diseases and/or injuries of the inner ear.
EFFECT: increased efficiency of compounds.
10 cl, 30 dwg, 1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE POLYMORPHIC FORM OF 6-FLUORO-9-METHYL-9H-BETA-CARBOLINE AND ITS APPLICATIONS | 2020 |
|
RU2806322C2 |
| THERAPY OF TINNITUS INDUCED BY COCHLEAR EXCITOTOXICITY | 2005 |
|
RU2380094C2 |
| DERIVATIVES OF BETA-CARBOLINE POSSESSING EFFECT OF PHOSPHODIESTERASE INHIBITORS, PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR ITS PREPARING, METHOD FOR INHIBITION OF PHOSPHODIESTERASE EFFECT (VARIANTS) AND METHOD FOR INCREASING CGMP CONCENTRATION | 2001 |
|
RU2271358C2 |
| BETA-CARBOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHODS FOR BINDING, ATTAINMENT OF AGONISTIC/ANTAGONISTIC EFFECT | 1999 |
|
RU2233841C2 |
| TETRAHYDROPYRIDO[3,4-B]INDOLE DERIVATIVES USEFUL IN TREATMENT OF CANCER | 2014 |
|
RU2664109C2 |
| METHODS FOR THE TREATMENT OF COCHLEAR SYNAPTOPATHY | 2017 |
|
RU2757276C2 |
| NEW COMPOUNDS USED AS POTASSIUM CHANNEL OPENERS | 2018 |
|
RU2779131C2 |
| NEW COMPOUNDS USED AS POTASSIUM CHANNEL OPENERS | 2018 |
|
RU2779111C2 |
| APPLICATION OF PHENOTHIAZINE DERIVATIVE TO PREVENT AND/OR TREAT HEARING LOSS | 2005 |
|
RU2377992C2 |
| APOPTOSIS MODULATING COMPOSITIONS WITH CONTROLLED RELEASE AND METHODS OF TREATING EAR DISEASES | 2009 |
|
RU2493828C2 |
